Oral antibiotics do not treat yeast infections. This is one of the most common points of confusion in women’s health. Antibiotics target bacteria, while yeast infections are caused by a fungus, most often Candida albicans. The oral medications that treat yeast infections are antifungals, and there are currently three FDA-approved options. In fact, antibiotics are one of the leading causes of yeast infections in the first place.
Why Antibiotics Don’t Work on Yeast
Bacteria and fungi are fundamentally different organisms, and the drugs designed to kill them work on completely different targets. Most antibiotics attack peptidoglycan, a structural component of bacterial cell walls that fungi simply don’t have. Antifungals, on the other hand, target ergosterol, a fatty molecule that makes up the fungal cell membrane. Without ergosterol, the yeast cell’s outer barrier breaks down and the organism dies. Giving an antibiotic for a yeast infection would be like using a car key to unlock your front door: the tool just doesn’t fit the lock.
How Antibiotics Can Cause Yeast Infections
Ironically, taking antibiotics is one of the most common triggers for developing a yeast infection. The vaginal microbiome relies on Lactobacillus bacteria to maintain an acidic environment that keeps Candida in check. Antibiotics are non-selective, meaning they kill beneficial Lactobacillus alongside whatever infection they’re treating. Once Lactobacillus is depleted, Candida can overgrow rapidly, and reestablishing that healthy bacterial balance is difficult. This is why many women develop yeast infections during or shortly after a course of antibiotics for something unrelated, like a sinus infection or UTI.
Fluconazole: The Standard Oral Treatment
Fluconazole (brand name Diflucan) is the first-line oral treatment for uncomplicated yeast infections and has been for decades. The CDC-recommended dose is a single 150 mg tablet taken once. It works by blocking an enzyme the yeast needs to produce ergosterol, which destabilizes the fungal cell membrane.
Most people notice symptom improvement within 24 hours, though the infection itself may take a few days to fully clear. For severe infections, full resolution can take one to two weeks. In clinical studies, a single dose produced a cure or improvement rate of about 96% by day 28, with complete mycological clearance (meaning the fungus was no longer detectable) in roughly 86% of patients.
Fluconazole requires a prescription. Common side effects are mild: headache, dizziness, diarrhea, stomach pain, and temporary changes in taste. More serious reactions involving the liver are rare but possible. Signs to watch for include yellowing of the skin or eyes, extreme fatigue, or dark urine. Fluconazole can also interact with common over-the-counter pain relievers like ibuprofen and naproxen, so mention any medications you’re already taking when getting your prescription.
Fluconazole and Pregnancy
Oral fluconazole is not recommended during pregnancy. Even low doses (under 150 mg) have been associated with an increased risk of miscarriage, and high doses taken during the first trimester have been linked to birth defects. Pregnant women are typically treated with topical antifungal creams or suppositories instead.
Ibrexafungerp: A Newer Option
Ibrexafungerp (brand name Brexafemme) was approved by the FDA in 2021 and represents the first new class of antifungal for yeast infections in over two decades. Unlike fluconazole, which targets ergosterol production, ibrexafungerp attacks the fungal cell wall by inhibiting an enzyme involved in building a structural component called glucan. This different mechanism means it can work against some strains that have become less responsive to fluconazole.
The dosing schedule is two 150 mg tablets taken twice in one day, about 12 hours apart, for a total of 600 mg. You can take it with or without food. It’s approved for adult and post-menarchal females with vaginal yeast infections. Like fluconazole, it is contraindicated in pregnancy, and a pregnancy test is recommended before starting treatment.
Oteseconazole for Recurrent Infections
If you get three or more yeast infections within a 12-month period, you have what’s classified as recurrent vulvovaginal candidiasis. This is a distinct clinical challenge because standard single-dose treatments clear each episode but don’t prevent the next one. Oteseconazole (brand name Vivjoa) was approved specifically for this pattern.
Oteseconazole is a newer type of azole antifungal designed for long-term prevention. In clinical trials published in NEJM Evidence, patients first cleared their active infection with fluconazole, then took oteseconazole on a tapering schedule: 150 mg daily for one week, followed by once weekly for 11 more weeks. The goal is to suppress Candida long enough to break the cycle of recurrence over a 48-week period.
Getting the Right Diagnosis First
Before seeking any oral treatment, it’s worth knowing that self-diagnosis of yeast infections is far less accurate than most people assume. In one study of women using a self-diagnostic approach, only about 69% correctly identified a yeast infection. Roughly a quarter of women who actually had a yeast infection missed it entirely, and about 8% treated themselves for a yeast infection they didn’t have. Symptoms like itching, discharge, and irritation overlap significantly with bacterial vaginosis and other conditions that require different treatments altogether.
A clinical exam with a swab test takes minutes and tells you exactly what you’re dealing with. This matters especially if you’re considering an oral antifungal, since all three options require a prescription. If your symptoms return within two months of treatment, or if over-the-counter topical treatments haven’t helped, clinical testing becomes even more important to rule out resistant strains or a different condition entirely.
Oral vs. Topical Antifungals
Over-the-counter topical treatments (creams and suppositories containing miconazole or clotrimazole) are available without a prescription and work well for many uncomplicated yeast infections. The main advantages of oral antifungals are convenience and the lack of mess. A single pill is simpler than a multi-day cream regimen. The clinical cure rates are comparable between oral and topical options for straightforward cases.
One practical note: topical creams and suppositories are oil-based and can weaken latex condoms and diaphragms. Oral antifungals don’t carry this issue. For recurrent infections or cases that haven’t responded to topical treatment, oral medications become the more practical choice since they reach fungal cells systemically rather than only on contact.